基本信息
views: 261
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Gottlieb’s investigations center on the physiology of congestive heart failure (CHF). This has included a particular interest in neurohormonal activation in CHF patients. Dr. Gottlieb was the United States principal investigator for MERIT, an international beta blocker survival trial in heart failure patients. He was also co-chairman of the mortality committee of BEST, a National Institutes of Health (NIH) and Veterans Affairs (VA) sponsored study of a different beta blocker. In addition, with the support of the local AHA, he is looking at the mechanism by which beta blockers may be effective. Other neurohormonal interests include investigation of vasopressin antagonists, adenosine antagonists, and endothelin antagonists.
Research Interests
Papers共 462 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nerea Mora-Ayestaran, MD,Angela Dispenzieri, MD, Arnt V. Kristen, MD, Mathew S. Maurer, MD, Igor Diemberger, MD, Brian M. Drachman, MD,Martha Grogan, MD, Pritam Gupta, PhD, Oliver Glass, PhD, Leslie Amass, PhD, Pablo Garcia-Pavia, MD, PhD,Michele Emdin,
JACC: Advancesno. 8 (2024): 101086
Cited0Views0Bibtex
0
0
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYno. 9 (2024): 932-950
Future cardiologyno. 1 (2023): 7-17
JAMAno. 5 (2023): 432-441
JOURNAL OF CARDIOVASCULAR NURSINGno. 4 (2023): E141-E164
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn